Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
1.240
+0.120 (10.71%)
At close: Jul 17, 2025, 4:00 PM
1.230
-0.010 (-0.81%)
After-hours: Jul 17, 2025, 7:05 PM EDT

Esperion Therapeutics Stock Forecast

ESPR's stock price has decreased by -54.58% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 6 analysts that cover Esperion Therapeutics stock have a consensus rating of "Buy" and an average price target of $6.5, which forecasts a 424.19% increase in the stock price over the next year. The lowest target is $3 and the highest is $16.

Price Target: $6.5 (+424.19%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$3.00$6.50$4.00$16
Change+141.94%+424.19%+222.58%+1190.3%
* Price targets were last updated on Jun 17, 2025.

Analyst Ratings

The average analyst rating for Esperion Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy222222
Buy233333
Hold111111
Sell111110
Strong Sell000000
Total677776

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$16
Strong BuyReiterates$16+1,190.32%Jun 17, 2025
Needham
Needham
Strong Buy
Maintains
$5$4
Strong BuyMaintains$5$4+222.58%May 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$16
Strong BuyReiterates$16+1,190.32%Apr 25, 2025
Needham
Needham
Strong Buy
Reiterates
$5
Strong BuyReiterates$5+303.23%Apr 25, 2025
Goldman Sachs
Goldman Sachs
Hold
Maintains
$4$3
HoldMaintains$4$3+141.94%Apr 17, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
349.44M
from 332.31M
Increased by 5.15%
Revenue Next Year
335.45M
from 349.44M
Decreased by -4.00%
EPS This Year
-0.19
from -0.28
EPS Next Year
-0.24
from -0.19
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
227.55M78.45M75.48M116.33M332.31M349.44M335.45M460.86M
Revenue Growth
53.37%-65.53%-3.79%54.14%185.66%5.15%-4.00%37.39%
EPS
-5.23-9.31-3.52-2.03-0.28-0.19-0.24-0.02
EPS Growth
--------
Forward PE
--------
No. Analysts
-----10107
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High438.9M433.9M639.5M
Avg349.4M335.5M460.9M
Low241.8M252.8M340.6M

Revenue Growth

Revenue Growth20252026202720282029
High
32.1%
24.2%
90.6%
Avg
5.2%
-4.0%
37.4%
Low
-27.2%
-27.7%
1.5%

EPS Forecast

EPS2025202620272028
High0.240.020.04
Avg-0.19-0.24-0.02
Low-0.56-0.43-0.13

EPS Growth

EPS Growth2025202620272028
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.